As evidence grows to support the use of psychedelic drugs in medicine, Dr Adam Winstock (UCL Institute of Epidemiology & Health Care) explores people’s polarised responses to these drugs and explains why this poses a thorny problem for policymakers.
Read: The Conversation
Close
